Orlistat is the only conventional drug used for obesity treatment through the inhibition of pancreatic lipase, but the side effects of the drug have ignited the hunt to develop plant-based lipase-inhibiting drugs for obesity [50]. Here, PNLIP is linked to obesity disorder.